These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 344101)

  • 1. Monitoring of a multi-modal schedule for the treatment of disseminated breast cancer.
    McIntosh IH; Bejrajati P; Goodfellow T; Palmer BV; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():471-6. PubMed ID: 344101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
    Webster DJ; Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of a multi-modal schedule with Corynebacterium parvum.
    McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP
    Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
    Vântu A; Bălănescu I; Stafidov N; Voiculeţ N
    Med Interne; 1982; 20(2):151-5. PubMed ID: 6181552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation.
    Fisher RA
    Dev Biol Stand; 1977 Apr 13-15; 38():461-6. PubMed ID: 608539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
    Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
    Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
    Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological response in patients receiving Corynebacterium parvum therapy.
    Osborn DE; Castro JE
    Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
    Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
    Thatcher N; Swindell R; Crowther D
    Clin Exp Immunol; 1979 Jan; 35(1):36-44. PubMed ID: 428146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen and immunity in breast cancer].
    Iakimova TP; Lozinskaia IN; Kozyreva TB; Pashchenko NS
    Med Radiol (Mosk); 1991; 36(10):15-7. PubMed ID: 1943545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slope analysis of plasma carcinoembryonic antigen levels in monitoring response to treatment in patients with metastatic carcinoma of the breast.
    Koch M; Paterson AH; McPherson TA
    Clin Oncol; 1980 Dec; 6(4):323-7. PubMed ID: 7460406
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
    Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
    Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects of short-term sequential immunomodulation with levamisole and Corynebacterium parvum in neoplastic pathology in the aged].
    Palmieri B; Marsiai M; Gasparini Casari M; Noera G
    Minerva Med; 1979 May; 70(25):1787-93. PubMed ID: 460632
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast.
    Chare MJ; Webster DJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of relationship between parity and level of carcinoembryonic antigen in women with breast cancer.
    Heller R; Fisher R; Nash A; Knapp J
    Anticancer Res; 1990; 10(6):1755-7. PubMed ID: 2285254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.